Tag: T1D
Innovative Research Aims to Engineer Localized Immune Tolerance for Type 1 Diabetes Treatment
March 27, 2024In an effort to address the unmet needs of immunoengineering for beta cell replacement in type 1 diabetes (T1D), Drs. Edward Phelps, Holger Russ, and Helen N. Jones are pioneering strategies aimed at locally controlling autoimmunity in T1D. Their research, poised to redefine treatment paradigms, focuses on leveraging immunomodulatory signals to promote tolerance towards grafted […]
Read more ยป